Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis

Prelamin A undergoes multistep processing to yield lamin A, a structural protein of the nuclear lamina. Prelamin A terminates with a CAAX motif, which triggers farnesylation of a C-terminal cysteine (the C of the CAAX motif), endoproteolytic release of the last three amino acids (the AAX), and methy...

Full description

Bibliographic Details
Main Authors: Stephen G. Young, Loren G. Fong, Susan Michaelis
Format: Article
Language:English
Published: Elsevier 2005-12-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S002222752032842X
_version_ 1818731723144298496
author Stephen G. Young
Loren G. Fong
Susan Michaelis
author_facet Stephen G. Young
Loren G. Fong
Susan Michaelis
author_sort Stephen G. Young
collection DOAJ
description Prelamin A undergoes multistep processing to yield lamin A, a structural protein of the nuclear lamina. Prelamin A terminates with a CAAX motif, which triggers farnesylation of a C-terminal cysteine (the C of the CAAX motif), endoproteolytic release of the last three amino acids (the AAX), and methylation of the newly exposed farnesylcysteine residue. In addition, prelamin A is cleaved a second time, releasing 15 more residues from the C terminus (including the farnesylcysteine methyl ester), generating mature lamin A. This second cleavage step is carried out by an endoplasmic reticulum membrane protease, ZMPSTE24. Interest in the posttranslational processing of prelamin A has increased with the recognition that certain progeroid syndromes can be caused by mutations that lead to an accumulation of farnesyl-prelamin A. Recently, we showed that a key cellular phenotype of these progeroid disorders, misshapen cell nuclei, can be ameliorated by inhibitors of protein farnesylation, suggesting a potential strategy for treating these diseases.In this article, we review the posttranslational processing of prelamin A, describe several mouse models for progeroid syndromes, explain the mutations underlying several human progeroid syndromes, and summarize recent data showing that misshapen nuclei can be ameliorated by treating cells with protein farnesyltransferase inhibitors.
first_indexed 2024-12-17T23:22:12Z
format Article
id doaj.art-3f0757fc37fe497cb77bf7a65fd3bc23
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-17T23:22:12Z
publishDate 2005-12-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-3f0757fc37fe497cb77bf7a65fd3bc232022-12-21T21:28:51ZengElsevierJournal of Lipid Research0022-22752005-12-01461225312558Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesisStephen G. Young0Loren G. Fong1Susan Michaelis2To whom correspondence should be addressed.; Division of Cardiology, Department of Internal Medicine, University of California, Los Angeles, CA 90095Division of Cardiology, Department of Internal Medicine, University of California, Los Angeles, CA 90095To whom correspondence should be addressed.; Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205Prelamin A undergoes multistep processing to yield lamin A, a structural protein of the nuclear lamina. Prelamin A terminates with a CAAX motif, which triggers farnesylation of a C-terminal cysteine (the C of the CAAX motif), endoproteolytic release of the last three amino acids (the AAX), and methylation of the newly exposed farnesylcysteine residue. In addition, prelamin A is cleaved a second time, releasing 15 more residues from the C terminus (including the farnesylcysteine methyl ester), generating mature lamin A. This second cleavage step is carried out by an endoplasmic reticulum membrane protease, ZMPSTE24. Interest in the posttranslational processing of prelamin A has increased with the recognition that certain progeroid syndromes can be caused by mutations that lead to an accumulation of farnesyl-prelamin A. Recently, we showed that a key cellular phenotype of these progeroid disorders, misshapen cell nuclei, can be ameliorated by inhibitors of protein farnesylation, suggesting a potential strategy for treating these diseases.In this article, we review the posttranslational processing of prelamin A, describe several mouse models for progeroid syndromes, explain the mutations underlying several human progeroid syndromes, and summarize recent data showing that misshapen nuclei can be ameliorated by treating cells with protein farnesyltransferase inhibitors.http://www.sciencedirect.com/science/article/pii/S002222752032842Xprotein prenylationlaminopathyagingSte24a-factorlamin A/C
spellingShingle Stephen G. Young
Loren G. Fong
Susan Michaelis
Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis
Journal of Lipid Research
protein prenylation
laminopathy
aging
Ste24
a-factor
lamin A/C
title Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis
title_full Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis
title_fullStr Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis
title_full_unstemmed Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis
title_short Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis
title_sort thematic review series lipid posttranslational modifications prelamin a zmpste24 misshapen cell nuclei and progeria new evidence suggesting that protein farnesylation could be important for disease pathogenesis
topic protein prenylation
laminopathy
aging
Ste24
a-factor
lamin A/C
url http://www.sciencedirect.com/science/article/pii/S002222752032842X
work_keys_str_mv AT stephengyoung thematicreviewserieslipidposttranslationalmodificationsprelaminazmpste24misshapencellnucleiandprogerianewevidencesuggestingthatproteinfarnesylationcouldbeimportantfordiseasepathogenesis
AT lorengfong thematicreviewserieslipidposttranslationalmodificationsprelaminazmpste24misshapencellnucleiandprogerianewevidencesuggestingthatproteinfarnesylationcouldbeimportantfordiseasepathogenesis
AT susanmichaelis thematicreviewserieslipidposttranslationalmodificationsprelaminazmpste24misshapencellnucleiandprogerianewevidencesuggestingthatproteinfarnesylationcouldbeimportantfordiseasepathogenesis